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Is a positive intracutaneous 
test induced by penicillin mediated 
by histamine? A cutaneous microdialysis study 
in penicillin-allergic patients
Line K. Tannert1*, Sidsel Falkencrone2, Charlotte G. Mortz1, Carsten Bindslev‑Jensen1 and Per Stahl Skov1,2
Abstract 
Background: Diagnostic workup of penicillin allergy comprises skin testing with penicillins, and patients are deemed 
allergic if skin test is positive. However, the literature suggests that skin test‑positive patients may be challenge‑nega‑
tive, indicating that the skin test may be falsely positive.
Objective: To investigate real‑time histamine release from a positive intracutaneous test induced by penicillin in 
patients with positive and negative challenges to penicillin.
Methods: Skin microdialysis was performed in 21 penicillin‑allergic patients with positive skin test, 13 non‑allergic 
volunteers serving as negative controls, and 7 grass pollen‑allergic patients serving as positive controls. Histamine was 
measured by microdialysis after skin test with penicillin/grass/NaCl. Penicillin challenge was subsequently performed 
in 12 of the patients.
Results: Only 10/21 patients (47.6%) were skin test positive at microdialysis. During microdialysis 13 single intracu‑
taneous tests were positive and histamine was detected in 4/13 occurring in four challenge positive patients. Thir‑
teen/21 patients (61.9%) were deemed allergic to penicillin; eight had positive skin test. Two patients with positive 
skin test were challenge negative. In grass pollen allergic patients, 7/7 had a positive intracutaneous test to grass and 
all released histamine in the wheals. All 13 negative controls had negative intracutaneous test to penicillin and no 
histamine release.
Conclusion: Histamine was only detected in the minority of positive intracutaneous tests with penicillin in penicillin‑
allergic patients. Other mediators may be involved.
Keywords: Histamine release, Penicillin‑allergy, Penicillin challenge, Penicillin intracutaneous test, Skin microdialysis
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Background
Identification of penicillin allergy is important, and the 
diagnostic work-up of patients with suspected penicillin 
allergy consists of several steps according to guidelines 
[1–3]. One step is skin testing, and if either the skin prick 
test (SPT) or the intracutaneous test (ICT) is positive, the 
patient is deemed to have a life-long allergy to penicillin. 
Positive skin testing is considered reliable for the diagno-
sis of penicillin allergy, but we recently demonstrated that 
60% of patients with a positive skin test were challenge-
negative to the culprit penicillin [4]. A few other studies 
also reported negative challenges in patients with a posi-
tive skin test [5–12].
A positive SPT or ICT to an allergen is generally 
accepted to be due to histamine that is released in an 
IgE-mediated reaction from the skin mast cells, although 
these cells contain a large number of other mediators and 
are considered to be the orchestrating cells in initiation 
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and dissemination of the allergic reaction [13]. Previ-
ous skin microdialysis studies have confirmed histamine 
release in wheals induced by grass in pollen-allergic 
patients [14]. Histamine release in wheals has also been 
demonstrated in non-IgE mediated reactions such as ice 
cube challenge in cold urticaria patients [15].
The aim of this study was to use skin microdialysis to 
investigate histamine release in patients with positive 
intracutaneous test to penicillin, and to compare the 
results with challenge outcome.
Methods
Participants
The following groups of patients and controls were 
included in the microdialysis study (Table 1).
  • Patients (n  =  21) with a case history of allergic 
reaction to a penicillin and positive intracutane-
ous test to at least one type of penicillin; 6 men and 
15 women, mean age 51  years (range 23–70  years). 
Of the 21 patients, 5 also had low levels of specific 
IgE to one or more penicillin (s-IgE). Median time 
interval between initial reaction and inclusion in the 
study was 40 months (range 1–240 months). Two of 
the patients had a case history of a non-immediate 
reaction occurring > 1 h after last administration of 
penicillin (Patient 12 and 13, Table 1). Two patients 
(Patient 8 and 17, Table 1) could not remember the 
exact timing from administration until reaction, and 
the remaining 17 had immediate reactions (occur-
ring < 1 h after last penicillin administration).
  • Healthy volunteers (n  =  13) without any aller-
gic reactions to penicillin treatment; 2 men and 11 
women, mean age 45  years (range 27–62  years), 
served as negative controls.
  • Grass pollen-allergic patients (n =  7); 3 men and 4 
women, mean age 35 years (range 27–51 years), with 
a positive skin prick test and s-IgE to grass, suffering 
from rhinoconjunctivitis during the grass pollen sea-
son, and serving as positive “classical allergic” controls.
Skin testing
An intracutaneous test with penicillin was performed 
during microdialysis with the penicillin(s) previously 
shown to induce a positive test. The following concentra-
tions were used: benzylpenicillin 20 mg/mL, amoxicillin 
20 mg/mL, ampicillin 20 mg/mL, dicloxacillin 1 mg/mL, 
and mecillinam 4 mg/mL both in patients and controls. 
Except for benzylpenicillin, concentrations were accord-
ing to European Network for Drug Allergy (ENDA) 
guidelines [16].
During microdialysis, ICT was performed with the 
penicillin(s) that was positive at first ICT. None of the 
patients were tested with the major or minor determi-
nants, PPL and MDM, during microdialysis. Skin testing 
with these reagents was not part of the routine testing at 
the Allergy Center, because Hjortlund et al. demonstrated 
that all patients with a positive PPL or MDM were also 
positive to benzylpenicillin [17]. However, 5/21 patients 
had a previous PPL and MDM skin test; one patient was 
positive to both but concomitantly positive to benzylpen-
icillin. Controls were tested with the same types of peni-
cillin as the patients.
Intracutaneous test with grass was performed with 
Phleum pratense extract in a dilution of 1000 SQ-U/mL 
(ALK-Abello, Hørsholm, Denmark).
The non-IgE dependent histamine releaser, codeine 
(codeine phosphate 1  mg/mL  RefLab®, Copenhagen, 
Denmark) was used as positive control to demon-
strate releasability of histamine from skin mast cells 
and to release residual histamine after a positive ICT 
induced by penicillin or grass. Intracutaneous test 
with isotonic saline 0.9% was the negative control in 
all participants.
ICT was always performed by injecting 50  µL, and 
reactions were considered positive if the wheal size diam-
eter was 3 mm larger than the initial bleb. ICT was read 
after 20 min, according to ENDA guidelines [2].
Regarding interpretation of the ICTs, all tests with pen-
icillin in the group of 21 patients were assessed blinded 
with photographs of the reactions by three independent 
consultants with experience in skin testing. Evaluations 
were in full compliance with the investigators’ primary 
evaluation.
Measurements of IgE to penicillins (s‑IgE)
S-IgE against penicillin V, penicillin G, amoxicillin (AX), 
and ampicillin (AMP) were measured using ImmunoCap 
(Thermo Fischer, Uppsala, Sweden). Results ≥ 0.35 kU/L 
were considered positive.
Penicillin challenge
Patients with a present or previous positive ICT elicited 
by penicillin were challenged with the culprit penicillin 
with increasing doses: starting at 1/100 of a therapeutic 
dose, followed by 1/10 and finally 1/1 with 30 min inter-
vals. Therapeutic doses were as follows: Pen V 800  mg, 
DX 1000 mg, MC 400 mg, AMP 500 mg, AX 750 mg, and 
AX + Cla 500/125 mg. For safety reasons, patients who 
had a delayed positive reaction to ICT (n = 3) or a recent 
anaphylactic reaction to penicillin (n = 2) were not chal-
lenged. Three patients refused challenge.
Skin microdialysis
Microdialysis is a minimally invasive technique for 
measuring continuous real-time release of extracellular 
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substances. In this study, we performed microdialysis 
as described by Petersen et  al. [18]. The microdialysis 
probes (EP Medical  Aps®, Copenhagen, Denmark) were 
semipermeable, linear, and equipped with a guide wire. 
The membrane had a molecular cut-off weight of 2 kDa 
(outer diameter = 216 µm, wall thickness = 8 µm) allow-
ing passive diffusion of small molecular substances. The 
probes were inserted intradermally and as superficially 
as possible into the volar forearm at a length of 2 cm of 
the skin using a 23G cannula. They were perfused with 
isotonic NaCl 0.9% at a rate of 3 µL/min. Prior to probe 
insertion, a local anesthetic and vasoconstrictor cream 
containing prilocaine and lidocaine  (Emla®, AstraZen-
eca, Södertälje, Sweden) was applied to the skin for 1 h 
to diminish pain and bleeding from the injection sites. 
 Emla® does not affect histamine degranulation from mast 
cells [19]. The dialysate was sampled in glass fiber-coated 
microtiter wells at 2-min intervals for 72  min (Fig.  1). 
Depending on the number of previous positive ICTs to 
penicillin, the participants had 2–4 probes inserted at 
least two cm apart. One probe in each participant was 
always a control probe where first ICT was done with 
NaCl and second ICT with codeine.
Baseline histamine values were collected for the first 
24 min after which two ICTs were performed above each 
probe. The first ICT was with penicillin(s) in the penicil-
lin-allergic (culprit penicillin(s)) patients and controls, 
grass in grass-pollen allergics, codeine in controls (posi-
tive control), or isotonic NaCl (negative control) that 
were injected at a distance of 1 mm from each probe. The 
second ICT after 48 min was always performed by injec-
tion of codeine to collect residual histamine from the skin 
around the probe. When a wheal developed, it always 
extended across the probe. Histamine collected from the 
microdialysate from the 2-min sampling period was ana-
lyzed spectrofluorometrically [20]. Detection level was 5 
nanogram of histamine.
Histamine release was determined in:
  • 12 baseline samples
  • 12 samples after first ICT
  • 12 samples after second ICT
Histamine area under curve (AUC)
As a supplement to peak histamine in wheals, the hista-
mine under the curve, histamine AUC, was calculated by 
summing up the trapezoids; area =  Σ((Y1 +  Y2)/2*(X2 
−  X1)) +  ((Yn +  Yn −  1)/2*(Xn −  Xn −  1)).The AUC 
comprises histaminerelease added for all 36 samples 
(baseline, first and second ICT).
Statistical analysis
We analyzed data using Kruskal–Wallis test and Mann–
Whitney test for ordinal data. Wilcoxon Signed Rank 
Test was used to determine whether ICT with penicillin 
induced significant release of histamine. P values < 0.05 
were considered significant. The statistical analyses were 
performed with SigmaPlot 13.0, Alfasoft, Sweden.
Results
Microdialysis experiments on grass pollen‑allergic patients 
and controls
As expected, ICT with grass pollen extract induced a wheal 
reaction in all seven grass pollen-allergic patients (median 
size 13  mm, range 7.5–16.5  mm) and a significant hista-
mine release from 2  min after first ICT (Fig.  2i). When 
codeine was injected at second ICT at the same site, non-
significant increases in wheal size (p = 0.46) and peak his-
tamine (p = 0.07) were observed, indicating that the grass 
pollen allergen released almost all the histamine from the 
skin mast cells. None of the controls developed wheals or 
released histamine after skin testing with penicillin (Fig. 2g).
When injecting codeine twice, the first codeine ICT 
induced, as expected, a wheal reaction (median size 
11  mm, range 10.0–12.5  mm) in all six controls and a 
significant histamine release from 2  min after the ICT 
(Fig. 2j). The second codeine ICT induced a non-signifi-
cant increase in wheal size in 3 of 7 controls (p = 0.12), 
and no peak histamine was observed (p  =  0.39). We 
therefore use codeine 1 mg/mL as a surrogate marker for 
total histamine content in the skin.
Control probe–codeine and histamine release
All penicillin patients (n  =  21), grass pollen patients 
(n = 7) and healthy controls (n = 13) reacted to ICT with 
First 
ICT
Second 
ICT
Baseline sampling Sampling Sampling
0-24 min 26-48 min 50-72 min
Fig. 1 Microdialysis flow chart. The first ICT after 24 min was performed with penicillin, grass, NaCl or codeine. The second ICT after 48 min was 
always performed with codeine
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Fig. 2 Time course of histamine release at baseline and after intracutaneous test. A 6‑microliter sample of dialysate was sampled from each probe 
every 2 min. Results are displayed as medians and 25th and 75th percentiles
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codeine with a wheal response showing a median diam-
eter of 12.5 mm (range 7.5–23.5 mm) and a concomitant 
significant histamine release (p  <  0.001), with a median 
peak histamine of 75.4  ng/mL (range 12.6–350.0  ng/
mL) (Fig.  2a–h). Compared with baseline, the ICT with 
physiological saline gave no significant histamine release 
(p  =  0.79), median peak histamine 8.6  ng/mL (range 
−7.6–35.5 ng/mL), and no wheals developed (Fig. 2b, d, 
f, h).
Microdialysis in penicillin‑allergic patients
During microdialysis, 13 positive ICTs with penicil-
lin developed in 10 patients; one patient was positive 
to three different penicillins, and one patient was posi-
tive to two penicillins. Histamine was detected in four 
of these positive ICTs, which had median size 13.8 mm 
(range 12.0–20.5 mm) and a significant histamine release 
from 2  min after the first ICT (Fig.  2c). These positive 
ICTs occurred in four patients with a case history of 
recent anaphylactic reaction or severe urticaria to phe-
noxymethylpenicillin (n  =  3) or mecillinam (n  =  1); 
all had negative s-IgE (Table  1). The nine positive ICTs 
without histamine had a median size of 11.3 mm (range 
8.5–15.0  mm) (Fig.  2a). The size did not differ signifi-
cantly from the ICTs with positive histamine release 
(p  =  0.17). No histamine was released in the negative 
ICTs in patients with a previous positive ICT to penicil-
lin (Fig. 2e). Histamine release after ICT with codeine in 
patients with a positive ICT was similar for patients with 
a penicillin-induced histamine release (median 165.4, 
range 88.2–270.1 ng/mL) and patients without a penicil-
lin-induced histamine release (median 166.2, range 5.5–
308.1  ng/mL) (p =  0.82). Mast cells in all patients were 
thus able to release histamine in detectable amounts. In 
patients with a positive ICT to penicillin (with or without 
histamine release), there was a significantly higher his-
tamine release after the second ICT with codeine com-
pared to patients with negative ICT to penicillin, controls 
or grass pollen-allergic patients (p < 0.05) (Fig. 2a, c, e, g, 
i, j).
Penicillin challenge
Intracutaneous test with the culprit penicillin was posi-
tive in only 10/21 (47.6%) of patients who previously had 
had a positive ICT. There was a tendency that the time 
interval from initial reaction until microdialysis was 
shorter for patients with positive ICT penicillin (median 
7.5  months) than patients with negative ICT (median 
27  months) (p  =  0.084). There were no differences 
regarding age or gender in the two groups. In all patients, 
the penicillin(s) eliciting the positive ICT was identical to 
that causing the initial reaction.
Among the 21 penicillin-allergic patients with a previ-
ous positive ICT, 13 were deemed allergic to penicillin: 7 
were challenge-positive, 2 had recent anaphylaxis, 1 had 
a systemic reaction to ICT, and 3 had a delayed positive 
ICT (Table 1). All seven patients with a positive challenge 
developed urticaria and/or angioedema during challenge, 
and all reactions were immediate i.e. commencing within 
1 h after intake of penicillin. Four of the seven challenge-
positive patients had become ICT negative since the ini-
tial evaluation whereas three were still positive; two of 
them had histamine release in the wheals. Additionally, 
two patients had positive s-IgE: one had negative reac-
tions to penicillin ICT and challenge, and the other had 
positive reactions to penicillin ICT and challenge (but no 
histamine release).
One patient with a systemic reaction to ICT (Patient 3, 
Table 1) had participated in microdialysis six months pre-
viously, where she had been s-IgE positive and had devel-
oped a positive ICT with no histamine release (and no 
systemic reaction). In the planning of challenge, micro-
dialysis was performed again and during this procedure 
the patient developed a systemic reaction 8 min after ICT 
with penicillin. Microdialysis was discontinued immedi-
ately, but the eluate already collected was analyzed and 
showed an increase in histamine significantly above base-
line from 4 min after the first ICT (data not shown and 
not included in Fig. 2).
Both of the patients with recent anaphylaxis (one also 
IgE positive) had positive ICT with histamine release in 
the wheal.
A positive ICT was present in 8 of 13 patients who 
were deemed penicillin-allergic in this setting (Patient 
1–13, Table 1), providing a sensitivity of 62%. Two of five 
patients with a negative challenge had positive ICT, giv-
ing a specificity of 60%. In contrast, the sensitivity of ICT 
with grass was 100%.
For positive ICTs with histamine release, a sensitivity of 
30% and specificity of 100% were found.
Total histamine released in the skin
There was no significant difference in total histamine 
release in patients with a positive ICT to penicillin with 
or without histamine release (p = 0.777), data not shown, 
and there was no difference in total histamine in patients 
with a previous positive ICT compared with controls 
(p =  0.729). Figure  3 compares all patients with a posi-
tive ICT to penicillin (with or without histamine release) 
and all with a negative ICT to penicillin (previously posi-
tive ICT to penicillin and controls). Patients with a posi-
tive ICT to penicillin had significantly higher histamine 
levels (median 1877.9 ng/mL, range 84.0–3368.2 ng/mL) 
than patients with a negative ICT to penicillin (median 
819.4  ng/mL, range 100.7–3883.5  ng/mL) (Fig.  3a). 
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Similar results were obtained from the negative control 
probe: a significantly higher total histamine release in the 
group with positive ICT (median 1606.1  ng/mL, range 
91.2–2934.8 ng/mL) than in the group with negative ICT 
to penicillin (median 605.8 ng/mL, range 79.2–4448.1 ng/
mL) (Fig. 3b).
Discussion
Previously, the microdialysis technique has been applied 
on grass pollen allergic patients demonstrating histamine 
release in grass pollen induced wheals [21]. Further, it has 
been demonstrated that there is a correlation between 
size of wheal and histamine concentration in wheal [22]. 
To our knowledge, skin microdialysis has never been 
used to investigate histamine release after skin testing 
with an antibiotic.
All penicillin-allergic patients included in this study 
had a previous positive ICT to penicillin, but only 10 of 
21 patients had a positive ICT to penicillin when entering 
the study 3–30 months after the initial positive ICT. This 
is in line with other studies describing declining rates of 
positive ICTs over time [4, 5, 23, 24]. In contrast, three 
patients (Patient 11–13, Table  1) showed a dual ICT 
response with an immediate reaction followed hours later 
by a delayed reaction that was persistently positive in our 
study, which is in agreement with data from Hjortlund 
et al. [17]. The fluctuating ICT response in the group of 
penicillin-allergic patients differs from the reproducible 
positive skin test to grass in the group of pollen allergic-
patients with a “classical” s-IgE-mediated reaction. The 
difference between the two groups was further empha-
sized by the fact that only a few of the penicillin-allergic 
patients were s-IgE positive to penicillin.
A positive ICT to penicillin was only partially corre-
lated to a positive challenge: eight ICT positive patients 
were deemed allergic whereas two were challenge nega-
tive. Four of the challenge positive patients had negative 
ICT to penicillin, but all had had positive ICT at the ini-
tial evaluation.
The four ICTs induced by histamine release all 
occurred in patients who were challenge-positive or had 
recent anaphylaxis to penicillin. Strikingly, none of these 
four patients had positive s-IgE, although one of the reac-
tions was caused by mecillinam where no s-IgE is avail-
able. Interestingly, there was no detectable histamine in 
the ICT of any of the patients with both immediate and 
delayed ICT reactions nor in challenge-negative patients.
We included a control group of non-allergic healthy 
individuals and a control group of verified grass pollen-
allergic patients. In accordance with previously published 
results, we found that all those with grass pollen allergy 
had a positive ICT to grass pollen and codeine, as well 
as histamine release in the wheal areas [14]. In the group 
of healthy individuals, only codeine caused a positive 
ICT and histamine release in the ICT area. These control 
experiments showed that the positive ICT was mediated 
Fig. 3 Total histamine release. Box plots showing total histamine release. a Significantly more total histamine release in patients with a positive ICT 
to penicillin compared with patients and controls with a negative ICT. b Demonstrates that the penicillin ICT positive patients also release signifi‑
cantly more histamine in total from the control probe. Results are displayed as medians, and the boundaries of the boxes represent the 25th and 
75th percentiles, the whiskers above and below the boxes are the 10th and 90th percentiles. Filled circle symbolizes an outlier
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by histamine release from the mast cells. As expected, 
codeine induced only a little histamine release in an ICT 
area previously challenged with grass pollen, indicating 
that the allergen caused release of almost all of the his-
tamine from the mast cells of patients with grass pollen 
allergy.
When codeine was injected at the same skin site as 
the previously injected penicillin, all penicillin-allergic 
patients showed identical codeine-induced histamine 
release independent of a positive or negative ICT to 
penicillin. It might therefore be questioned whether his-
tamine always is a key mediator in a positive penicillin-
induced ICT. This is further emphasized by our finding 
that only 4 of 13 positive ICTs showed histamine release.
We consider codeine-induced histamine release as a 
surrogate marker of total mast cell histamine content in 
the ICT area and codeine has previously been used to 
evaluate total histamine in skin from patients with cold 
urticaria [15]. This is based on two observations. First, 
codeine-induced histamine release was usually higher 
than allergen-induced histamine release, demonstrating 
that codeine is a very potent histamine-releasing agent. 
Secondly, we found that a second injection of codeine 
at the same skin site induced only a marginal, and not 
significant, increased histamine release, indicating that 
most histamine was already released from mast cells by 
the first codeine injection.
The lack of histamine release in most of the penicillin-
allergic patients during penicillin ICT points to other 
mechanisms than mast cell histamine release speaking 
against the general concept that histamine plays a pivotal 
role in these reactions. Other mediators such as leukot-
rienes [25], prostaglandins [26], platelet-activating fac-
tor (PAF) [27], bradykinin [26], or cytokines [28] might 
thus be upregulated in the patients’ skin. It is also possi-
ble that other cell types than mast cells are involved, and/
or that non-IgE mediated mechanisms are involved such 
as nerve-mast cell interactions [29]. Patients with a posi-
tive ICT to penicillin released more total histamine than 
patients with a previous positive ICT and controls. This 
may indicate that patients with a positive ICT to penicil-
lin have more mast cells in the skin, or that the histamine 
content in each mast cell is higher.
Conclusion
This study demonstrates that the majority of cutaneous 
reactions to penicillin in penicillin-allergic patients may 
be caused by other mast cells mediators than histamine 
and may be non-IgE mediated. This contrasts with the 
results in patients with classic IgE mediated allergic reac-
tions (to grass pollen), who all had near-maximum hista-
mine release in wheals after grass pollen ICT.
In order to elucidate the complexity of penicillin-aller-
gic reactions, future studies should be aimed at detecting 
other mediators in penicillin ICT wheals and search for 
possible non-IgE mediated allergy-like reactions.
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